Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

Teledoc Needs at Least a Year to Prove Itself to Investors

By Chris Lau, InvestorPlace Contributor

Teledoc stock is under selling pressure because its Livongo acquisition is hurting results and adding to an uncertain future.

Buy Intel Before INTC Stock Rebounds Soon

By Chris Lau, InvestorPlace Contributor

INTC stock fell more than it should have after the company posted quarterly earnings featuring slow revenue growth.

A Solid October for Alibaba Stock Is a Good Sign for Future Months

By Chris Lau, InvestorPlace Contributor

Alibaba is flying higher on reports of Jack Ma’s public appearance and a new computer chip for its cloud computing servers.

Opendoor Stock Could Sustain This Uptrend Into the Foreseeable Future

By Chris Lau, InvestorPlace Contributor

Investors are awaiting for Opendoor to post strong earnings report next month, with a higher outlook potentially lifting the stock more.

Momentum on Skillz Stock Has Faded, So It May Be Time to Take the Loss

By Chris Lau, InvestorPlace Contributor

Shorts have a heavy bet against Skillz, speculating that user acquisition costs will grow faster than revenue, leading to bigger losses next.

Load More